Masimo (NASDAQ:MASI) Issues FY 2024 Earnings Guidance

Masimo (NASDAQ:MASI - Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 4.100-4.100 for the period, compared to the consensus estimate of 4.030. The company issued revenue guidance of $2.1 billion-$2.1 billion, compared to the consensus revenue estimate of $2.1 billion. Masimo also updated its FY 2025 guidance to 4.900-5.100 EPS.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on MASI shares. BTIG Research increased their price objective on Masimo from $166.00 to $170.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Wells Fargo & Company increased their price target on shares of Masimo from $171.00 to $193.00 and gave the company an "overweight" rating in a research report on Wednesday, December 11th. Needham & Company LLC restated a "hold" rating on shares of Masimo in a report on Thursday. Stifel Nicolaus reaffirmed a "buy" rating and set a $190.00 target price (up previously from $170.00) on shares of Masimo in a report on Friday, November 22nd. Finally, Piper Sandler boosted their price target on shares of Masimo from $180.00 to $210.00 and gave the stock an "overweight" rating in a research note on Wednesday, December 18th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Masimo presently has an average rating of "Moderate Buy" and an average price target of $179.67.

Masimo Trading Down 1.2 %

MASI traded down $2.13 during trading on Thursday, hitting $169.94. 992,781 shares of the stock traded hands, compared to its average volume of 535,351. The firm has a 50-day moving average of $169.03 and a 200 day moving average of $139.75. Masimo has a 12-month low of $101.61 and a 12-month high of $180.97. The firm has a market capitalization of $9.10 billion, a P/E ratio of 117.20 and a beta of 1.01. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11.

Masimo (NASDAQ:MASI - Get Free Report) last posted its earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.14. The company had revenue of $504.60 million for the quarter, compared to analysts' expectations of $502.87 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. Masimo's quarterly revenue was up 5.4% on a year-over-year basis. During the same period last year, the firm earned $0.63 earnings per share. Equities research analysts anticipate that Masimo will post 4.03 EPS for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.